MCID: BLT006
MIFTS: 46

Bilateral Breast Cancer

Categories: Cancer diseases

Aliases & Classifications for Bilateral Breast Cancer

MalaCards integrated aliases for Bilateral Breast Cancer:

Name: Bilateral Breast Cancer 12 54 15 71
Bilateral Breast Carcinoma 12 6

Classifications:



External Ids:

Disease Ontology 12 DOID:6741
NCIt 49 C8287
UMLS 71 C0281267

Summaries for Bilateral Breast Cancer

Disease Ontology : 12 A breast carcinoma that is characterized by an individual having breast cancer in both breasts, either simultaneously or at different times.

MalaCards based summary : Bilateral Breast Cancer, also known as bilateral breast carcinoma, is related to ataxia-telangiectasia and synchronous bilateral breast carcinoma. An important gene associated with Bilateral Breast Cancer is BRCA2 (BRCA2 DNA Repair Associated), and among its related pathways/superpathways are ERK Signaling and Gene Expression. The drugs Sargramostim and leucovorin have been mentioned in the context of this disorder. Affiliated tissues include breast, ovary and lung, and related phenotypes are Decreased viability and Decreased viability

Related Diseases for Bilateral Breast Cancer

Diseases related to Bilateral Breast Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 348, show less)
# Related Disease Score Top Affiliating Genes
1 ataxia-telangiectasia 30.4 CHEK2 BRCA2 BRCA1 ATM
2 synchronous bilateral breast carcinoma 29.8 PGR BRCA2 BRCA1
3 papillary serous adenocarcinoma 29.6 PGR BRCA2 BRCA1
4 gynecomastia 29.5 PGR ESR1 ERBB2
5 thyroid carcinoma 29.5 PTEN PIK3CA CDH1
6 liposarcoma 29.5 PTEN PIK3CA CDKN2A
7 cervical adenocarcinoma 29.4 PTEN ESR1 ERBB2 CDKN2A
8 comedo carcinoma 29.2 PGR ESR1 ERBB2
9 estrogen excess 29.1 PTEN PGR ESR1
10 mammary paget's disease 29.1 PGR ESR1 ERBB2
11 gastrointestinal stromal tumor 29.1 PTEN ERBB2 CDKN2A CDH1
12 breast fibroadenoma 28.9 PGR ESR1 ERBB2 BRCA1
13 breast disease 28.8 PGR FHIT ESR1 ERBB2 BRCA2 BRCA1
14 leiomyosarcoma 28.8 PGR ESR1 CDKN2A
15 papillary carcinoma 28.7 PGR ESR1 ERBB2 CDH1
16 tubular adenocarcinoma 28.7 PGR ESR1 ERBB2 CDH1
17 lobular neoplasia 28.6 PGR ESR1 ERBB2 CDH1 BRCA2 BRCA1
18 female breast cancer 28.5 PGR PALB2 ESR1 ERBB2 BRCA2 BRCA1
19 carcinosarcoma 28.4 PTEN PIK3CA PGR ERBB2 CDH1
20 serous cystadenocarcinoma 28.4 PTEN PIK3CA PGR ERBB2 BRCA2 BRCA1
21 hereditary breast ovarian cancer syndrome 28.3 RAD51 PTEN PALB2 MLH1 CHEK2 CDKN2A
22 mucinous adenocarcinoma 28.2 PGR MLH1 ESR1 ERBB2 CDKN2A
23 squamous cell carcinoma 28.2 PTEN PIK3CA FHIT ERBB2 CHEK2 CDKN2A
24 adenocarcinoma 28.2 PTEN PIK3CA MLH1 ERBB2 CDKN2A CDH1
25 thyroid gland cancer 28.1 PTEN PIK3CA ESR1 ERBB2 CDKN2A CDH1
26 in situ carcinoma 28.0 PTEN PGR ESR1 ERBB2 CDKN2A CDH1
27 cowden syndrome 28.0 RAD51 PTEN PIK3CA PALB2 MLH1 ERBB2
28 li-fraumeni syndrome 27.9 PTEN PALB2 MLH1 ESR1 ERBB2 CHEK2
29 breast ductal carcinoma 27.9 PTEN PGR ESR1 ERBB2 CDH1 BRCA2
30 endometrial adenocarcinoma 27.4 PTEN PGR MLH1 ESR1 ERBB2 CDKN2A
31 ductal carcinoma in situ 27.4 PTEN PIK3CA PGR ESR1 ERBB2 CDKN2A
32 adenoid cystic carcinoma 27.1 PTEN PIK3CA PGR ERBB2 CHEK2 CDKN2A
33 cervical cancer 27.0 PTEN PIK3CA MLH1 FHIT ESR1 ERBB2
34 pancreatic cancer 26.7 RAD51 PTEN PIK3CA PALB2 MLH1 FHIT
35 breast cancer 26.5 RAD51 PTEN PIK3CA PGR PALB2 MLH1
36 endometrial cancer 26.1 RAD51 PTEN PIK3CA PGR MLH1 ESR1
37 gastric cancer 26.0 PTEN PIK3CA PGR MLH1 FHIT ESR1
38 prostate cancer 25.9 RAD51 PTEN PIK3CA PGR ESR1 ERBB2
39 sporadic breast cancer 25.9 RAD51 PTEN PGR PALB2 MLH1 FHIT
40 ovarian cancer 24.7 RAD51 PTEN PIK3CA PGR PALB2 NBR1
41 hereditary site-specific ovarian cancer syndrome 10.6 BRCA2 BRCA1
42 rare malignant breast tumor 10.6 BRCA2 BRCA1
43 tetraploidy 10.5 BRCA2 BRCA1
44 cancerophobia 10.5 BRCA2 BRCA1
45 nosophobia 10.5 BRCA2 BRCA1
46 scrotum squamous cell carcinoma 10.5 CHEK2 ATM
47 breast-ovarian cancer, familial 2 10.4 BRCA2 BRCA1
48 tracheoesophageal fistula with or without esophageal atresia 10.4 PALB2 BRCA2
49 familiar ovarian carcinoma 10.4 PIK3CA BRCA1
50 breast cystic hypersecretory carcinoma 10.3 ERBB2 CDH1
51 breast-ovarian cancer, familial 1 10.3 NBR2 BRCA2 BRCA1
52 mediastinum liposarcoma 10.3 CDKN2A ATM
53 thyroid hurthle cell adenoma 10.3 PTEN PIK3CA
54 dysgerminoma 10.3 PTEN BRCA2 BRCA1
55 ovarian clear cell adenofibroma 10.3 PTEN PIK3CA
56 parotid gland adenoid cystic carcinoma 10.3 ERBB2 CDKN2A
57 breast squamous cell carcinoma 10.3 PIK3CA ERBB2
58 nephrolithiasis/osteoporosis, hypophosphatemic, 2 10.3 BRCA1 ATM
59 mediastinum sarcoma 10.2 CDKN2A ATM
60 vulvar seborrheic keratosis 10.2 PTEN CDKN2A
61 bloom syndrome 10.2 RAD51 BRCA2 BRCA1 ATM
62 familial ovarian cancer 10.2 ESR1 BRCA2 BRCA1
63 nijmegen breakage syndrome 10.2 RAD51 CHEK2 BRCA1 ATM
64 cecal benign neoplasm 10.2 PTEN CDKN2A
65 cecum adenoma 10.2 PTEN CDKN2A
66 trichothiodystrophy 1, photosensitive 10.2 RAD51 CHEK2 BRCA1 ATM
67 fanconi anemia, complementation group d1 10.2 RAD51 PALB2 BRCA2 BRCA1
68 fanconi anemia, complementation group j 10.2 RAD51 PALB2 BRCA2 BRCA1
69 anaplastic ependymoma 10.2 PTEN PALB2
70 bile duct cystadenoma 10.2 ESR1 CHEK2 ATM
71 vulvar intraepithelial neoplasia 10.2 CDKN2A CDH1
72 esophageal adenosquamous carcinoma 10.1 ERBB2 CDH1
73 esophagus verrucous carcinoma 10.1 CDKN2A CDH1
74 suppressor of tumorigenicity 3 10.1 FHIT CDKN2A
75 peutz-jeghers syndrome 10.1
76 li-fraumeni syndrome 2 10.1
77 breast papillomatosis 10.1 ERBB2 CDKN2A
78 microinvasive gastric cancer 10.1 MLH1 ERBB2 CDH1
79 signet ring cell adenocarcinoma 10.1 MLH1 ERBB2 CDH1
80 werner syndrome 10.1 RAD51 MLH1 BRCA1 ATM
81 uterine body mixed cancer 10.1 PTEN PIK3CA ERBB2
82 small intestine cancer 10.1 MLH1 ERBB2 CDH1
83 rectum adenocarcinoma 10.1 PIK3CA MLH1 ERBB2
84 infant gynecomastia 10.1
85 contractures, pterygia, and variable skeletal fusions syndrome 1a 10.1 PTEN MLH1 BRCA2 BRCA1
86 atrophic vulva 10.1 ESR1 CDKN2A
87 endometrioid ovary carcinoma 10.1 PTEN PIK3CA MLH1
88 autosomal recessive cerebellar ataxia 10.1 RAD51 CHEK2 BRCA2 BRCA1 ATM
89 seckel syndrome 10.0 RAD51 CHEK2 BRCA2 BRCA1 ATM
90 bile duct adenocarcinoma 10.0 PTEN ERBB2 CDH1
91 intrahepatic cholangiocarcinoma 10.0 PTEN ERBB2 CDH1
92 ovarian clear cell carcinoma 10.0 PTEN PIK3CA MLH1
93 lipid-rich breast carcinoma 10.0 PGR ERBB2
94 sebaceous adenoma 10.0 MLH1 ESR1
95 telangiectasis 10.0
96 dysphagia 10.0
97 peritoneum cancer 10.0 ERBB2 CDKN2A BRCA2 BRCA1
98 breast duct papilloma 10.0 PTEN PGR
99 cowden syndrome 1 10.0 PTEN PIK3CA BRCA2 BRCA1
100 apocrine adenosis of breast 10.0 PGR ERBB2
101 esophagus adenocarcinoma 10.0 ERBB2 CDKN2A CDH1
102 uterine corpus serous adenocarcinoma 10.0 PTEN PIK3CA ERBB2 BRCA1
103 pancreatic ductal carcinoma 9.9 ERBB2 CDKN2A CDH1
104 respiratory system benign neoplasm 9.9 PTEN CDKN2A CDH1
105 breast adenoid cystic carcinoma 9.9 PGR ERBB2
106 retinal cancer 9.9 PTEN CDKN2A ATM
107 oral cancer 9.9 FHIT CDKN2A CDH1
108 breast mucinous carcinoma 9.9 PGR ERBB2
109 rare cancer of corpus uteri 9.9 PTEN PIK3CA ERBB2
110 barrett's adenocarcinoma 9.9 RAD51 FHIT ERBB2 CDKN2A
111 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.9
112 osteogenic sarcoma 9.9
113 ataxia and polyneuropathy, adult-onset 9.9
114 body mass index quantitative trait locus 1 9.9
115 hypogonadotropic hypogonadism 9.9
116 neutropenia 9.9
117 primary cutaneous b-cell lymphoma 9.9 PTEN CDKN2A
118 anal squamous cell carcinoma 9.9 PIK3CA MLH1 CDKN2A
119 cystadenoma 9.9 PTEN PGR BRCA1
120 bartholin's gland adenoid cystic carcinoma 9.9 PGR ESR1
121 chronic tympanitis 9.9 PGR ESR1
122 bartholin's gland adenoma 9.9 PGR ESR1
123 granulomatous endometritis 9.9 PGR ESR1
124 bartholin's gland benign neoplasm 9.9 PGR ESR1
125 vestibular gland benign neoplasm 9.9 PGR ESR1
126 tongue disease 9.9 PTEN CDKN2A CDH1
127 epstein-barr virus-associated gastric carcinoma 9.8 PIK3CA CDKN2A CDH1
128 vagina leiomyoma 9.8 PGR CDKN2A
129 endometrial squamous cell carcinoma 9.8 PGR CDKN2A
130 lung leiomyoma 9.8 PGR ESR1
131 congenital hypoplastic anemia 9.8 RAD51 PALB2 CHEK2 BRCA2 BRCA1 ATM
132 vulvar syringoma 9.8 PGR ESR1
133 trigonitis 9.8 PGR ESR1
134 vagina leiomyosarcoma 9.8 PGR ESR1
135 penile cancer 9.8 PTEN PIK3CA CDKN2A
136 adult type testicular granulosa cell tumor 9.8 PGR ESR1
137 endometrial mucinous adenocarcinoma 9.8 PGR CDKN2A
138 tongue cancer 9.8 PTEN CDKN2A CDH1
139 salivary gland carcinoma 9.8 ERBB2 CDKN2A BRCA1
140 breast leiomyoma 9.8 PGR ESR1
141 colorectal adenoma 9.8 MLH1 CDKN2A CDH1
142 skin melanoma 9.8 PTEN MLH1 ERBB2 CDKN2A
143 xeroderma pigmentosum, variant type 9.8 RAD51 MLH1 CHEK2 BRCA2 BRCA1 ATM
144 scirrhous adenocarcinoma 9.8 PGR ERBB2 CDH1
145 intravenous leiomyomatosis 9.8 PGR ESR1
146 pheochromocytoma 9.8
147 multiple endocrine neoplasia, type iia 9.8
148 lymphoma, hodgkin, classic 9.8
149 lymphoma, non-hodgkin, familial 9.8
150 aplastic anemia 9.8
151 myxoid liposarcoma 9.8
152 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.8
153 diffuse large b-cell lymphoma 9.8
154 adrenal gland pheochromocytoma 9.8
155 hemoglobinopathy 9.8
156 liver disease 9.8
157 collecting duct carcinoma 9.8
158 breast liposarcoma 9.8
159 b-cell lymphoma 9.8
160 48,xyyy 9.8
161 vaginal benign neoplasm 9.8 PGR CDKN2A
162 primary peritoneal carcinoma 9.8 PGR ERBB2 BRCA2 BRCA1
163 linitis plastica 9.8 PGR ERBB2 CDH1
164 mucoepidermoid carcinoma 9.8 ERBB2 CDKN2A CDH1
165 hepatocellular carcinoma 9.8
166 systemic lupus erythematosus 9.8
167 acrofacial dysostosis 1, nager type 9.8
168 mirror movements 1 9.8
169 neurofibromatosis, type iv, of riccardi 9.8
170 kindler syndrome 9.8
171 pituitary adenoma, prolactin-secreting 9.8
172 asthma 9.8
173 ewing sarcoma 9.8
174 leukemia, acute lymphoblastic 9.8
175 congenital short bowel syndrome 9.8
176 hyperprolactinemia 9.8
177 angiosarcoma 9.8
178 follicular lymphoma 9.8
179 crest syndrome 9.8
180 ovarian sex-cord stromal tumor 9.8
181 myxofibrosarcoma 9.8
182 osteonecrosis 9.8
183 dermatomyositis 9.8
184 lymphocytic leukemia 9.8
185 sarcoma 9.8
186 goiter 9.8
187 graves' disease 9.8
188 urticaria 9.8
189 diffuse scleroderma 9.8
190 vascular disease 9.8
191 calcinosis 9.8
192 hypogonadism 9.8
193 dermatitis 9.8
194 neurilemmoma 9.8
195 histiocytosis 9.8
196 cellulitis 9.8
197 appendix adenocarcinoma 9.8
198 plexopathy 9.8
199 systemic scleroderma 9.8
200 spindle cell sarcoma 9.8
201 thyroiditis 9.8
202 hypogonadotropism 9.8
203 situs inversus 9.8
204 hyperthyroidism 9.8
205 peritonitis 9.8
206 intestinal obstruction 9.8
207 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.8
208 lupus erythematosus 9.8
209 pulmonary embolism 9.8
210 bronchiectasis 9.8
211 keloid disorder 9.8
212 radiation induced cancer 9.8
213 raynaud phenomenon 9.8
214 paraneoplastic syndromes 9.8
215 pituitary tumors 9.8
216 cystadenocarcinoma 9.8 PIK3CA PGR ERBB2
217 liver leiomyoma 9.8 PGR ESR1
218 gastric diffuse adenocarcinoma 9.8 PGR ERBB2 CDH1
219 barrett esophagus 9.8 FHIT ERBB2 CDKN2A CDH1
220 intestinal benign neoplasm 9.7 PTEN PIK3CA MLH1 CDH1
221 laryngeal squamous cell carcinoma 9.7 PTEN FHIT CDKN2A CDH1
222 mammographic density 9.7 PGR ESR1
223 chordoma 9.7 PTEN CDKN2A CDH1
224 dysplastic nevus syndrome 9.7 PALB2 MLH1 CDKN2A BRCA2 BRCA1
225 vulva cancer 9.7 PTEN PIK3CA ERBB2 CDKN2A
226 bizarre leiomyoma 9.7 PGR ESR1
227 vaginal endometrial stromal sarcoma 9.7 PGR ESR1
228 skin squamous cell carcinoma 9.7 PTEN MLH1 CDKN2A CDH1
229 bile duct cancer 9.7 PTEN ERBB2 CDKN2A CDH1
230 glassy cell carcinoma of the cervix 9.7 PGR ESR1 ERBB2
231 breast scirrhous carcinoma 9.7 PGR ESR1 ERBB2
232 oncocytic breast carcinoma 9.7 PGR ESR1 ERBB2
233 breast papillary carcinoma 9.7 PGR ESR1 ERBB2
234 breast metaplastic carcinoma 9.7 PGR ESR1 ERBB2
235 glioma susceptibility 1 9.7 PTEN PIK3CA ERBB2 CDKN2A
236 breast malignant phyllodes tumor 9.7 PGR ESR1 ERBB2
237 progesterone-receptor negative breast cancer 9.7 PGR ESR1 ERBB2
238 mantle cell lymphoma 9.7 PTEN PIK3CA CDKN2A ATM
239 apocrine adenocarcinoma 9.7 PGR ESR1 ERBB2
240 breast osteosarcoma 9.7 PGR ESR1 ERBB2
241 cribriform carcinoma 9.7 PGR ESR1 ERBB2
242 intraductal breast neoplasm 9.7 PGR ESR1 ERBB2
243 progesterone-receptor positive breast cancer 9.7 PGR ESR1 ERBB2
244 intraductal papilloma 9.7 PGR ESR1 ERBB2
245 adenosarcoma 9.7 PGR ESR1 ERBB2
246 sweat gland disease 9.7 PGR ESR1 ERBB2
247 sweat gland cancer 9.7 PGR ESR1 ERBB2
248 ocular cancer 9.7 FHIT CDKN2A BRCA2
249 large cell neuroendocrine carcinoma 9.6 PGR ESR1 ERBB2
250 lung squamous cell carcinoma 9.6 PTEN PIK3CA CDH1 BRCA2 BRCA1
251 amelogenesis imperfecta, type ig 9.6 PGR ESR1 ERBB2
252 endometriosis of ovary 9.6 PTEN PGR ESR1
253 adenomyoma 9.6 PGR MLH1 ESR1
254 teeth hard tissue disease 9.6 PGR ESR1 ERBB2
255 adenoma 9.6 PIK3CA MLH1 CDKN2A CDH1
256 adenosquamous carcinoma 9.6 PTEN PIK3CA PGR
257 uterine benign neoplasm 9.6 PTEN PGR ESR1
258 reproductive organ benign neoplasm 9.6 PTEN PGR ESR1
259 vagina sarcoma 9.6 PGR ESR1
260 cholangiocarcinoma 9.6 PTEN PIK3CA FHIT ERBB2 CDH1
261 cervical squamous cell carcinoma 9.6 PIK3CA MLH1 CDKN2A CDH1
262 endosalpingiosis 9.6 PGR ESR1 BRCA2 BRCA1
263 pancreatic ductal adenocarcinoma 9.6 PTEN ERBB2 CDKN2A CDH1 BRCA2
264 fanconi anemia, complementation group a 9.6 RAD51 PALB2 MLH1 CHEK2 BRCA2 BRCA1
265 kidney cancer 9.6 PTEN PIK3CA FHIT CDKN2A
266 teratoma 9.5 PTEN ESR1 CDKN2A CDH1
267 spindle cell carcinoma 9.5 PGR ESR1 CDH1
268 colon adenocarcinoma 9.5 PTEN PIK3CA MLH1 ERBB2 CDH1
269 estrogen-receptor negative breast cancer 9.5 PGR ESR1 ERBB2 BRCA1
270 ovarian seromucinous carcinoma 9.5 PGR ESR1 CDKN2A
271 leukemia, chronic lymphocytic 9.5 PTEN ERBB2 CDKN2A BRCA2 ATM
272 clear cell adenocarcinoma 9.5 PIK3CA PGR ESR1
273 vulvar leiomyoma 9.5 PGR ESR1 CDKN2A
274 vaginal cancer 9.5 PGR ESR1 CDKN2A
275 t-cell leukemia 9.5 PTEN PIK3CA CHEK2 CDKN2A ATM
276 endocervical carcinoma 9.5 PGR ESR1 CDKN2A
277 progesterone resistance 9.5 PGR ESR1
278 endocervical adenocarcinoma 9.5 PGR ESR1 CDKN2A
279 papillary adenocarcinoma 9.5 PGR ERBB2 CDH1 BRCA2 BRCA1
280 thoracic cancer 9.4 PGR ESR1 ERBB2 BRCA1
281 papilloma 9.4 PTEN ESR1 CHEK2 CDKN2A CDH1
282 ovarian cystadenocarcinoma 9.4 PTEN PIK3CA ERBB2 CDKN2A BRCA2 BRCA1
283 gliosarcoma 9.4 PTEN ERBB2 CDKN2A
284 oral cavity cancer 9.4 PTEN PIK3CA ERBB2 CDKN2A CDH1
285 lipid-rich carcinoma 9.4 PGR ESR1 ERBB2 CDH1
286 breast neuroendocrine neoplasm 9.4 PGR ESR1 ERBB2 CDH1
287 microglandular adenosis 9.4 PGR ESR1 ERBB2 CDH1
288 endometrial hyperplasia 9.4 PTEN PGR MLH1 ESR1
289 inflammatory breast carcinoma 9.4 PGR ESR1 ERBB2 CDH1
290 breast juvenile papillomatosis 9.4 PGR ESR1 ERBB2 BRCA2 BRCA1
291 glioma 9.4 PTEN PIK3CA ERBB2 CDKN2A BRCA2 ATM
292 intracystic papillary adenoma 9.4 PGR ESR1 ERBB2 BRCA2 BRCA1
293 breast sarcoma 9.4 PIK3CA PGR ESR1 ERBB2
294 vulvar disease 9.3 PIK3CA PGR ERBB2 CDKN2A
295 adenomyosis 9.3 PTEN PGR ESR1 CDH1
296 nasopharyngeal carcinoma 9.3 PTEN PIK3CA ERBB2 CDKN2A CDH1
297 colorectal adenocarcinoma 9.3 PTEN MLH1 ERBB2 CDKN2A CDH1 ATM
298 myelodysplastic syndrome 9.3 RAD51 PTEN FHIT ERBB2 CHEK2 CDKN2A
299 transitional cell carcinoma 9.3 PTEN MLH1 FHIT ERBB2 CDKN2A CDH1
300 basal cell carcinoma 9.3 PTEN PALB2 MLH1 CHEK2 CDKN2A CDH1
301 melanoma 9.3 PTEN PIK3CA ERBB2 CDKN2A CDH1 BRCA2
302 cervical mucinous adenocarcinoma 9.3 PTEN PGR ESR1 CDKN2A
303 peritoneal mesothelioma 9.3 PTEN PGR ESR1 CDKN2A
304 renal cell carcinoma, papillary, 1 9.2 PTEN PIK3CA ERBB2 CDKN2A CDH1 ATM
305 estrogen-receptor positive breast cancer 9.2 PIK3CA PGR ESR1 ERBB2 BRCA1
306 lymphoma 9.2 PIK3CA CHEK2 CDKN2A CDH1 BRCA2 BRCA1
307 myeloma, multiple 9.2 PTEN ESR1 ERBB2 CDKN2A CDH1 ATM
308 autosomal genetic disease 9.2 RAD51 PTEN MLH1 ESR1 CHEK2 BRCA2
309 breast adenocarcinoma 9.1 PIK3CA PGR ESR1 ERBB2 CHEK2
310 thoracic benign neoplasm 9.1 PGR ESR1 ERBB2 CDH1 BRCA2 BRCA1
311 breast benign neoplasm 9.1 PGR ESR1 ERBB2 CDH1 BRCA2 BRCA1
312 tonsil cancer 9.0 PGR ESR1 ERBB2 CDKN2A CDH1
313 gallbladder cancer 9.0 PTEN PIK3CA MLH1 FHIT ERBB2 CDKN2A
314 bladder urothelial carcinoma 9.0 PTEN PIK3CA MLH1 FHIT ERBB2 CDKN2A
315 squamous cell carcinoma, head and neck 8.9 PTEN PIK3CA MLH1 FHIT ERBB2 CDKN2A
316 fallopian tube carcinoma 8.9 PTEN PGR PALB2 ESR1 ERBB2 BRCA2
317 rare breast tumor 8.8 PTEN PIK3CA PALB2 ESR1 ERBB2 CHEK2
318 breast carcinoma in situ 8.8 PTEN PGR ESR1 ERBB2 CDH1 BRCA2
319 wilms tumor 1 8.8 PGR PALB2 ESR1 ERBB2 CHEK2 CDH1
320 oropharynx cancer 8.8 PTEN PIK3CA PGR ERBB2 CDKN2A CDH1
321 mixed cell type cancer 8.8 PTEN PIK3CA PGR ESR1 ERBB2 CDH1
322 hypertrophy of breast 8.8 PTEN PIK3CA PGR ESR1 ERBB2 BRCA2
323 melanoma, cutaneous malignant 1 8.8 PTEN PIK3CA PALB2 MLH1 CHEK2 CDKN2A
324 lynch syndrome 8.8 PTEN PIK3CA PALB2 MLH1 CHEK2 CDKN2A
325 meningioma, familial 8.7 PTEN PGR ESR1 ERBB2 CDKN2A CDH1
326 medulloblastoma 8.7 RAD51 PTEN PIK3CA ERBB2 CDKN2A CDH1
327 neuroblastoma 8.7 PTEN PIK3CA ESR1 ERBB2 CDKN2A CDH1
328 luminal breast carcinoma 8.6 PTEN PIK3CA PGR ESR1 ERBB2 CDH1
329 bladder cancer 8.6 PTEN PIK3CA MLH1 FHIT ERBB2 CDKN2A
330 female reproductive endometrioid cancer 8.5 PTEN PIK3CA PGR MLH1 ESR1 ERBB2
331 suppression of tumorigenicity 12 8.5 PTEN PIK3CA ESR1 ERBB2 CDKN2A CDH1
332 leukemia, acute myeloid 8.5 RAD51 PTEN ESR1 ERBB2 CHEK2 CDKN2A
333 ovarian serous cystadenocarcinoma 8.5 PTEN PIK3CA PGR ERBB2 CDKN2A CDH1
334 lung cancer susceptibility 3 8.5 PTEN PIK3CA FHIT ESR1 ERBB2 CDKN2A
335 gastric adenocarcinoma 8.4 PTEN PIK3CA MLH1 FHIT ESR1 ERBB2
336 cell type benign neoplasm 8.4 PTEN PIK3CA PGR MLH1 ESR1 CDKN2A
337 pancreatic adenocarcinoma 8.3 PTEN PIK3CA MLH1 ESR1 ERBB2 CDKN2A
338 esophageal cancer 8.2 RAD51 PTEN PIK3CA MLH1 FHIT ERBB2
339 uterine carcinosarcoma 8.1 PTEN PIK3CA PGR MLH1 ESR1 ERBB2
340 uterine corpus cancer 8.1 PTEN PIK3CA PGR MLH1 ESR1 ERBB2
341 ovary epithelial cancer 8.1 PTEN PIK3CA PGR ESR1 ERBB2 CDKN2A
342 malignant ovarian surface epithelial-stromal neoplasm 8.1 PTEN PIK3CA PGR ESR1 ERBB2 CDKN2A
343 pre-malignant neoplasm 8.1 PTEN PIK3CA PGR ESR1 ERBB2 CDKN2A
344 glioblastoma multiforme 7.9 RAD51 PTEN PIK3CA MLH1 ESR1 ERBB2
345 ovary adenocarcinoma 7.6 PTEN PIK3CA PGR MLH1 ESR1 ERBB2
346 colorectal cancer 7.6 RAD51 PTEN PIK3CA MLH1 FHIT ESR1
347 ovarian disease 7.2 PTEN PIK3CA PGR PALB2 MLH1 ESR1
348 lung cancer 7.1 RAD51 PTEN PIK3CA PGR MLH1 FHIT

Graphical network of the top 20 diseases related to Bilateral Breast Cancer:



Diseases related to Bilateral Breast Cancer

Symptoms & Phenotypes for Bilateral Breast Cancer

GenomeRNAi Phenotypes related to Bilateral Breast Cancer according to GeneCards Suite gene sharing:

26 (showing 21, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00055-A-2 10.77 PIK3CA
2 Decreased viability GR00221-A-1 10.77 CDKN2A ESR1 PIK3CA
3 Decreased viability GR00221-A-2 10.77 BRCA1 CHEK2 ESR1 PIK3CA
4 Decreased viability GR00221-A-3 10.77 ATM BRCA1 CDKN2A CHEK2 ERBB2
5 Decreased viability GR00221-A-4 10.77 ATM CDKN2A CHEK2 ERBB2 ESR1 PIK3CA
6 Decreased viability GR00301-A 10.77 BRCA1
7 Decreased viability GR00342-S-2 10.77 CHEK2
8 Decreased viability GR00402-S-2 10.77 ATM BRCA1 CDKN2A CHEK2 ERBB2 ESR1
9 Decreased viability in esophageal squamous lineage GR00235-A 10.15 BRCA1 BRCA2 CDH1 CDKN2A CHEK2 ERBB2
10 Decreased homologous recombination repair frequency GR00151-A-1 10.06 BRCA1 RAD51
11 Decreased homologous recombination repair frequency GR00151-A-2 10.06 BRCA1 RAD51
12 Decreased homologous recombination repair frequency GR00236-A-3 10.06 BRCA1 BRCA2 PALB2 RAD51
13 Increased homologous recombination repair frequency GR00236-A-1 10 BRCA1 BRCA2 PALB2 PGR RAD51
14 Increased homologous recombination repair frequency GR00236-A-2 10 ATM BRCA1 BRCA2 PALB2 PGR RAD51
15 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.84 ATM BRCA1 BRCA2 CDKN2A CHEK2 MLH1
16 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.84 ATM BRCA1 BRCA2 CDKN2A CHEK2 MLH1
17 Apoptosis resistance GR00093-A-0 9.78 ATM CDKN2A CHEK2 PTEN
18 Increased viability with MLN4924 (a NAE inhibitor) GR00250-A-3 9.7 ATM BRCA1 BRCA2 CHEK2 MLH1 PALB2
19 Decreased viability after ionizing radiation GR00232-A-2 9.58 ATM BRCA1 BRCA2
20 Decreased viability with cisplatin GR00101-A-4 9.5 BRCA1 BRCA2 RAD51
21 Synthetic lethal with cisplatin GR00101-A-1 9.13 BRCA1 BRCA2 RAD51

MGI Mouse Phenotypes related to Bilateral Breast Cancer:

45 (showing 17, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.43 ATM BRCA1 BRCA2 CDH1 CDKN2A CHEK2
2 homeostasis/metabolism MP:0005376 10.32 ATM BRCA1 BRCA2 CDH1 CDKN2A CHEK2
3 embryo MP:0005380 10.31 ATM BRCA1 BRCA2 CDH1 CDKN2A ERBB2
4 endocrine/exocrine gland MP:0005379 10.3 ATM BRCA1 BRCA2 CDH1 CDKN2A CHEK2
5 cardiovascular system MP:0005385 10.27 ATM BRCA1 CDH1 CDKN2A ERBB2 ESR1
6 hematopoietic system MP:0005397 10.27 ATM BRCA1 BRCA2 CDKN2A CHEK2 ESR1
7 immune system MP:0005387 10.27 ATM BRCA1 BRCA2 CDH1 CDKN2A CHEK2
8 growth/size/body region MP:0005378 10.25 ATM BRCA1 BRCA2 CDH1 CDKN2A ERBB2
9 integument MP:0010771 10.25 ATM BRCA1 BRCA2 CDH1 CDKN2A ERBB2
10 mortality/aging MP:0010768 10.24 ATM BRCA1 BRCA2 CDH1 CDKN2A CHEK2
11 digestive/alimentary MP:0005381 10.2 BRCA1 BRCA2 CDH1 CDKN2A ERBB2 ESR1
12 neoplasm MP:0002006 10.1 ATM BRCA1 BRCA2 CDH1 CDKN2A CHEK2
13 limbs/digits/tail MP:0005371 10.01 BRCA1 BRCA2 ERBB2 ESR1 NBR1 PALB2
14 muscle MP:0005369 9.87 BRCA1 CDKN2A ERBB2 ESR1 PGR PIK3CA
15 nervous system MP:0003631 9.85 ATM BRCA1 BRCA2 CDKN2A CHEK2 ERBB2
16 reproductive system MP:0005389 9.73 ATM BRCA1 BRCA2 CDH1 CDKN2A CHEK2
17 skeleton MP:0005390 9.28 BRCA1 BRCA2 CDKN2A ERBB2 ESR1 NBR1

Drugs & Therapeutics for Bilateral Breast Cancer

Drugs for Bilateral Breast Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 36, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sargramostim Approved, Investigational Phase 2 123774-72-1, 83869-56-1
2
leucovorin Approved Phase 2 58-05-9 6006 143
3
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
4
Sulindac Approved, Investigational Phase 2 38194-50-2 5352 1548887
5
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
6
Emodepside Investigational, Vet_approved Phase 2 155030-63-0
7 Vaccines Phase 2
8 Vitamins Phase 2
9 Trace Elements Phase 2
10 Vitamin B Complex Phase 2
11 Alkylating Agents Phase 2
12 Micronutrients Phase 2
13 Vitamin B9 Phase 2
14 Nutrients Phase 2
15 Hematinics Phase 2
16 Immunosuppressive Agents Phase 2
17 Folate Phase 2
18 Immunologic Factors Phase 2
19 Epothilone B Phase 2
20 Epothilones Phase 2
21 Antimitotic Agents Phase 2
22 Estrogens Phase 2
23 Hormone Antagonists Phase 2
24 Hormones Phase 2
25 Antirheumatic Agents Phase 2
26 Anti-Inflammatory Agents Phase 2
27 Aromatase Inhibitors Phase 2
28 Anti-Inflammatory Agents, Non-Steroidal Phase 2
29 Cyclooxygenase Inhibitors Phase 2
30 Analgesics, Non-Narcotic Phase 2
31 Estrogen Antagonists Phase 2
32 Steroid Synthesis Inhibitors Phase 2
33 Estrogen Receptor Antagonists Phase 2
34 Analgesics Phase 2
35
Progesterone Approved, Vet_approved Phase 1 57-83-0 5994
36 Progestins Phase 1

Interventional clinical trials:

(showing 9, show less)
# Name Status NCT ID Phase Drugs
1 Double Blind, Parallel Groups, Controlled, Randomized Phase II Trial to Evaluate Vaccination With Folate Receptor Alpha Peptide Vaccine With GM-CSF as Vaccine Adjuvant Following Oral Cyclophosphamide Versus GM-CSF/Placebo to Prevent Recurrence in Patients With Triple Negative Breast Cancer Recruiting NCT03012100 Phase 2 Cyclophosphamide
2 A Phase II Randomized Study of Ixabepilone vs. Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2/Neu-Negative Breast Cancer Active, not recruiting NCT00877500 Phase 2 Ixabepilone
3 NSAID Effects on Clinical and Imaging Breast Biomarkers Active, not recruiting NCT01761877 Phase 2 Sulindac
4 A Phase 1b Study of M6620 in Combination With Radiation Therapy to Overcome Therapeutic Resistance in Chemotherapy Resistant Triple Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer Not yet recruiting NCT04052555 Phase 1 ATR Kinase Inhibitor M6620
5 Genetic Counseling for Breast Cancer Survivors (GC for BC) Completed NCT02451735
6 Longitudinal Observational Study About the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer Completed NCT03669952
7 Dept. of Radiation Oncology, PGIMER, Chandigarh Completed NCT04175821
8 Establishment of Normal High Risk Breast Epithelial Cell Cultures, and A High Risk Cell Line and Tissue Repository From Breast Tissue From Women at High Risk of Breast Cancer Completed NCT00032201
9 Genome-Wide Association Study of Radiation Exposure and Bilateral Breast Cancer Active, not recruiting NCT00903591

Search NIH Clinical Center for Bilateral Breast Cancer

Genetic Tests for Bilateral Breast Cancer

Anatomical Context for Bilateral Breast Cancer

MalaCards organs/tissues related to Bilateral Breast Cancer:

40
Breast, Ovary, Lung, Thyroid, Lymph Node, Skin, Testes

Publications for Bilateral Breast Cancer

Articles related to Bilateral Breast Cancer:

(showing 830, show less)
# Title Authors PMID Year
1
A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer. 54 61
19649703 2010
2
A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family. 54 61
19288190 2010
3
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. 54 61
20104584 2010
4
Robotic resection of intraductal neoplasm of the pancreas. 54 61
19698031 2009
5
A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region. 54 61
19393826 2009
6
Age at onset of bilateral breast cancer, the presence of hereditary BRCA1, BRCA2, CHEK2 gene mutations and positive family history of cancer. 54 61
19372713 2009
7
Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. 54 61
19153073 2009
8
Accuracy of the BRCAPRO model among women with bilateral breast cancer. 54 61
19127556 2009
9
Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer. 54 61
19629752 2009
10
Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer. 54 61
18264724 2008
11
Altered DNA binding by the human Rad51-R150Q mutant found in breast cancer patients. 54 61
17666788 2007
12
[Analysis of the mutation of BRCA1 gene in 70 Uigur women breast cancer patients in Xinjiang]. 54 61
17557253 2007
13
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. 54 61
16331614 2006
14
Association of common ATM polymorphism with bilateral breast cancer. 54 61
15756685 2005
15
A comparison of bilateral breast cancers in BRCA carriers. 54 61
15941968 2005
16
BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients. 54 61
15319244 2004
17
ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer. 54 61
14562025 2003
18
Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. 54 61
12673797 2003
19
Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer. 54 61
12151349 2002
20
BRCA1 and BRCA2 mutations in Russian familial breast cancer. 54 61
11793480 2002
21
Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing. 54 61
11802208 2002
22
Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. 54 61
11556836 2001
23
BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. 54 61
11389159 2001
24
Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. 54 61
11149425 2001
25
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. 54 61
11130383 2000
26
Frequency of germ-line BRCA1 mutations among Spanish families from a Mediterranean area. 54 61
10737987 2000
27
Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure. 54 61
10699917 2000
28
Identification of Rad51 alteration in patients with bilateral breast cancer. 54 61
10807537 2000
29
BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer. 54 61
10573018 1999
30
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2. 54 61
10188893 1999
31
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. 54 61
9333265 1997
32
Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. 54 61
9157994 1997
33
BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. 54 61
9145677 1997
34
Germline mutation of BRCA1 in Japanese breast cancer families. 54 61
7627958 1995
35
Estrogen and progesterone receptor content in bilateral breast cancer. 54 61
7651928 1995
36
Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1. 54 61
8281142 1993
37
Bilateral breast cancer: one disease or two? 54 61
1663803 1991
38
Carcinoma erysipeloides as the presenting feature for bilateral breast carcinoma. 61
32031679 2020
39
Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test. 61
32019277 2020
40
Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors. 61
31926487 2020
41
The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancer. 61
31933123 2020
42
Endometrial Endometrioid Carcinoma With Ovarian Metastasis Showing Morula-like Features in a Patient With Cowden Syndrome: A Case Report. 61
30676432 2020
43
Systemic investigations into the molecular features of bilateral breast cancer for diagnostic purposes. 61
31835926 2020
44
Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer. 61
31119730 2020
45
Surgery for Killian-Jamieson diverticulum: a report of two cases. 61
31933008 2020
46
A Nanoscale Metal-Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy. 61
31642163 2020
47
Skin-sparing Mastectomy and Immediate Nipple Graft for Large, Ptotic Breast. 61
31897337 2019
48
Worse characteristics can predict survival effectively in bilateral primary breast cancer: A competing risk nomogram using the SEER database. 61
31663683 2019
49
Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment. 61
31520209 2019
50
The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients. 61
31368036 2019
51
National trends of synchronous bilateral breast cancer incidence in the United States. 61
31325072 2019
52
Skin and lung toxicity in synchronous bilateral breast cancer treated with volumetric-modulated arc radiotherapy: a mono-institutional experience. 61
30875061 2019
53
From a variant of unknown significance to pathogenic: Reclassification of a large novel duplication in BRCA2 by high-throughput sequencing. 61
31724318 2019
54
Phase II Study of Proton Beam Radiation Therapy for Patients With Breast Cancer Requiring Regional Nodal Irradiation. 61
31449469 2019
55
Effects of High Anxiety Scores on Surgical and Overall Treatment Plan in Patients with Breast Cancer Treated with Neoadjuvant Therapy. 61
31615949 2019
56
Synchronous and metachronous bilateral breast cancer: clinicopathologic characteristics and prognostic outcomes. 61
31351153 2019
57
A rare case of cancer-to-cancer metastasis: breast cancer to renal cell cancer : Case report and review of literature. 61
31041627 2019
58
Does race predict survival for women with invasive breast cancer? 61
31206623 2019
59
Bilateral erector spinae nerve block using one injection for bilateral breast cancer surgery. 61
30776776 2019
60
Evaluation of fixed-jaw IMRT and tangential partial-VMAT radiotherapy plans for synchronous bilateral breast cancer irradiation based on a dosimetric study. 61
31483573 2019
61
From uncertainty to pathogenicity: clinical and functional interrogation of a rare TP53 in-frame deletion. 61
30886117 2019
62
High relative levels of satellite alpha transcripts predict increased risk of bilateral breast cancer and multiple primary cancer in patients with breast cancer and lacking BRCA‑related clinical features. 61
31173247 2019
63
Pseudo skin flash on VMAT in breast radiotherapy: Optimization of virtual bolus thickness and HU values. 61
31221409 2019
64
Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan. 61
30309218 2019
65
The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008-2018). 61
31038845 2019
66
Local Tumor Staging of Breast Cancer: Digital Mammography versus Digital Mammography Plus Tomosynthesis. 61
30964425 2019
67
Differential Profile of BRCA1 vs. BRCA2 Mutated Families: A Characterization of the Main Differences and Similarities in Patients. 61
31244284 2019
68
Chemotherapy-induced posterior reversible encephalopathy syndrome: Three case reports. 61
31083272 2019
69
Tamoxifen related Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): A case report and literature review of this possible association. 61
30799070 2019
70
Breast cancer mortality in synchronous bilateral breast cancer patients. 61
30804429 2019
71
Evaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiation. 61
30935400 2019
72
Does the subtype of breast cancer affect the diagnostic performance of axillary ultrasound for nodal staging in breast cancer patients? 61
30732971 2019
73
Whole Exome Sequencing in the Accurate Diagnosis of Bilateral Breast Cancer: a Case Study. 61
30941240 2019
74
Metachronous bilateral triple-negative breast cancer associated with neurofibromatosis type 1: A case report. 61
30854057 2019
75
[A Case of Synchronous Bilateral Breast Cancer in an Elderly Patient]. 61
30914557 2019
76
Esophageal metastasis of breast cancer during endocrine therapy for pleural dissemination 21 years after breast surgery: a case report. 61
30771195 2019
77
[Locoregional control and patterns of locoregional failure in women with breast cancer treated by highly conformal electron beam irradiation]. 61
30595340 2019
78
When breast cancer gets complicated. A case report of synchronous bilateral breast cancers with discordant tumor markers from the primary to nodes with findings of a sentinel internal mammary subpectoral lymph node. 61
30788096 2019
79
Results of a nationwide survey on Japanese clinical practice in breast-conserving radiotherapy for breast cancer. 61
30476198 2019
80
Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy. 61
31998635 2019
81
The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans. 61
30622657 2019
82
Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk? 61
30165125 2019
83
Techniques for Treating Bilateral Breast Cancer Patients Using Pencil Beam Scanning Technology. 61
31998816 2019
84
Body mass index and diabetes are important prognostic signatures for bilateral breast cancer prognosis. 61
30618092 2019
85
Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families. 61
29988077 2018
86
New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer. 61
30553462 2018
87
Surgical treatment of early stage breast cancer in the Auckland and Waikato regions of New Zealand. 61
30253442 2018
88
Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography. 61
30396659 2018
89
The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations. 61
30014164 2018
90
Synchronous and metachronous bilateral breast cancer: A long-term experience. 61
30610782 2018
91
[Clinicopathologic and molecular characteristics of synchronous bilateral breast cancer]. 61
30317747 2018
92
Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours. 61
30141242 2018
93
Clinico-pathological characteristics and treatment outcome in invasive lobular carcinoma of the breast: An Indian experience. 61
30829268 2018
94
Clinical and Pathologic Features of Clinically Occult Synchronous Bilateral Breast Cancers. 61
28935459 2018
95
Brevibacterium casei bacteraemia in a port-a-cath carrier patient: a case report. 61
30246770 2018
96
Surgeon Variability and Factors Predicting for Reoperation Following Breast-Conserving Surgery. 61
29786129 2018
97
Synchronous bilateral breast cancer patients submitted to conservative treatment and brachytherapy - The experience of a service. 61
30127671 2018
98
Including internal mammary lymph nodes in radiation therapy for synchronous bilateral breast cancer: an international survey of treatment technique and clinical priorities. 61
29869775 2018
99
Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population. 61
29254601 2018
100
Sequential Sentinel Node Scintigraphy With Planar and SPECT/CT Images Revealed Contralateral Drainage From Ipsilateral Breast Tumor Relapse in a Patient With Bilateral Breast Cancer. 61
29659396 2018
101
Delayed Recurrent and Bilateral Breast Cancer in Patients With Partial Poland's Anomaly: Report of 2 Rare Cases and Review of the Literature. 61
29475749 2018
102
68Ga-Prostate-Specific Membrane Antigen PET/CT in Triple-Negative Breast Cancer. 61
29578872 2018
103
Radiation therapy of synchronous bilateral breast carcinoma (SBBC) using multiple techniques. 61
28988893 2018
104
Bilateral Metachronous Breast Carcinoma: A Rare Case Report. 61
29744328 2018
105
Incidence and tumour characteristics of bilateral and unilateral interval breast cancers at screening mammography. 61
29306176 2018
106
Breast Cancer is Common in Women With Ovarian Malignant Mixed Mullerian Tumors. 61
26757435 2018
107
Characterization of mutations in BRCA1/2 and the relationship with clinic-pathological features of breast cancer in a hereditarily high-risk sample of chinese population. 61
29435039 2018
108
Germline breast cancer susceptibility gene mutations and breast cancer outcomes. 61
29566657 2018
109
Increasing survival of metastatic breast cancer through locoregional surgery. 61
28994557 2018
110
Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer. 61
29315233 2018
111
Synchronous bilateral breast cancer: A case report of heterogeneous estrogen receptor status. 61
30391732 2018
112
Favorable progression-free survival in women with two different histopathological subtypes of bilateral breast cancer. 61
30589050 2018
113
Next generation sequencing is informing phenotype: a TP53 example. 61
28509937 2018
114
Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family. 61
29346284 2018
115
Bilateral synchronous breast cancer developed as metachronous malignancy after therapy of other primaries. 61
30084474 2018
116
Pre-operative Axillary Ultrasound-Guided Needle Sampling in Breast Cancer: Comparing the Sensitivity of Fine Needle Aspiration Cytology and Core Needle Biopsy. 61
29063297 2018
117
Treatment of axillary web syndrome using instrument assisted soft tissue mobilization and thoracic manipulation for associated thoracic rotation dysfunction. 61
28854081 2018
118
The robustness of dual isocenter VMAT radiation therapy for bilateral lymph node positive breast cancer. 61
29254586 2017
119
Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery. 61
28976793 2017
120
Treatment of bilateral breast cancer and regional nodes using an opposed lateral beam arrangement. 61
28867548 2017
121
Bilateral Breast Cancer with Neurofibromatosis Type 1 Patient: Case Report. 61
29082380 2017
122
The role of BRCA status on prognosis in patients with triple-negative breast cancer. 61
29152070 2017
123
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers. 61
28477318 2017
124
Comparison of Helical Tomotherapy and Direct Tomotherapy in Bilateral Whole Breast Irradiation in a Case of Bilateral Synchronous Grade 1 and Stage 1 Breast Cancer. 61
28935854 2017
125
Radiologic manifestation of the malignant peripheral nerve sheet tumor involving the brachial plexus. 61
28828137 2017
126
Breast cancer metastases to the thyroid gland - an uncommon sentinel for diffuse metastatic disease: a case report and review of the literature. 61
28934992 2017
127
First clinical report of helical tomotherapy with simultaneous integrated boost for synchronous bilateral breast cancer. 61
28707988 2017
128
Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer. 61
28423363 2017
129
CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial. 61
28592386 2017
130
Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients. 61
28281021 2017
131
Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost. 61
28224401 2017
132
Synchronous Bilateral Breast Cancer in a Patient With Nager Syndrome. 61
28139434 2017
133
The Role of Genetic Testing in Patients With Breast Cancer: A Review. 61
28423155 2017
134
Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers. 61
28730766 2017
135
pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy - A retrospective pooled analysis of individual patients data of four German neoadjuvant trials. 61
28063331 2017
136
Dynamic 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts. 61
27541026 2017
137
Synchronous Bilateral Breast Cancer With Discordant Histology. 61
28412779 2017
138
PALB2 mutation in a woman with bilateral breast cancer: A case report. 61
28413668 2017
139
Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families. 61
27025497 2017
140
Synchronous and bilateral oncocytic carcinoma of the breast: A case report and review of the literature. 61
28454314 2017
141
First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report. 61
28184945 2017
142
Refractory Tamoxifen-Induced Keratopathy Despite Drug Withdrawal. 61
27918356 2017
143
Gastric metastasis of bilateral breast cancer. 61
28280631 2017
144
Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway. 61
28241424 2017
145
Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysis. 61
28770017 2017
146
The Preventive Intervention of Hereditary Breast Cancer. 61
29282679 2017
147
Bilateral Breast Cancer After Prophylactic Bilateral Pulmonary Irradiation. 61
28272005 2017
148
Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan. 61
27826754 2017
149
Totally implantable venous access port via the femoral vein in a femoral port position with CT-venography. 61
27658579 2016
150
Bilateral Breast Irradiation Using Hybrid Volumetric Modulated Arc Therapy (h-VMAT) Technique: A Planning Case Report. 61
28083458 2016
151
Simultaneous integrated bilateral breast and nodal irradiation with volumetric arc therapy: case report and literature review. 61
27716877 2016
152
Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer. 61
26467036 2016
153
Co-existence of a giant cell tumour of the tendon sheath and schwannoma in a patient with bilateral breast cancer: A potential cause of false positive findings in 18F-FDG PET/CT studies. 61
27329560 2016
154
[Right Hemi-Colectomy for a Metastatic Transverse Colon Tumor from Breast Cancer Following Bilateral Breast Cancer Resection - A Case Report]. 61
28133217 2016
155
Bilateral breast cancer resection performed under the bilateral transversus thoracic muscle plane block. 61
27555202 2016
156
The effect of epigenetic silencing and TP53 mutation on the expression of DLL4 in human cancer stem disorder. 61
27542210 2016
157
Evaluation of Clinicopathological Findings on 255 cases of Inoperable Locally Advanced Breast Carcinoma: A Tertiary Care Experience. 61
28191801 2016
158
Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033). 61
27650678 2016
159
Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. 61
27345635 2016
160
Helical tomotherapy for bilateral breast cancer: Clinical experience. 61
27253152 2016
161
Challenges of treating incidental synchronous bilateral breast cancer with differing tumour biology. 61
27539136 2016
162
Incidental unilateral and bilateral ductal carcinoma in situ encountered in the surgical management of young male gynecomastia. 61
27612041 2016
163
Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR. 61
27307436 2016
164
Relevance of intraoperative indocyanine green injection in breast reconstruction using DIEP procedure for abdominal scars. 61
27066700 2016
165
KOHBRA BRCA risk calculator (KOHCal): a model for predicting BRCA1 and BRCA2 mutations in Korean breast cancer patients. 61
26763880 2016
166
BILATERAL BREAST CANCER: DIAGNOSIS AND PROGNOSIS. 61
27483711 2016
167
The risk of contralateral breast cancer in daughters of women with and without breast cancer. 61
25920602 2016
168
[Relationship of clinicopathological features and chemotherapeutic outcomes in women with BRCA1 and BRCA2 mutation-negative familial breast cancer]. 61
26988823 2016
169
Autoantibodies directed to centromere protein F in a patient with BRCA1 gene mutation. 61
26868636 2016
170
[Synchronous bilateral breast cancer: experiences in the Mohammed VI Cancer Treatment Center, CHU Ibn Rochd, Casablanca]. 61
28292084 2016
171
[Synchronous bilateral breast cancer and pregnancy: about 3 cases at Joliot Curie institute of Dakar (Senegal)]. 61
27279967 2016
172
Long-term effects of first degree family history of breast cancer in young women: Recurrences and bilateral breast cancer. 61
26399280 2016
173
Image-guided intensity-modulated radiotherapy for refractory bilateral breast cancer in a patient with extensive cutaneous metastasis in the chest and abdominal walls. 61
27284253 2016
174
Femoral Placement of Totally Implantable Venous Access Ports in Patients with Bilateral Breast Cancer. 61
26855441 2016
175
Unilateral Arm Urticaria Presenting as a Paraneoplastic Manifestation of Metachronous Bilateral Breast Cancer. 61
26933416 2016
176
Disease evolution and heterogeneity in bilateral breast cancer. 61
27904775 2016
177
EVOLUTION OF SYNCHRONOUS BILATERAL BREAST CARCINOMA IN A YOUNG PATIENT. 61
27125095 2016
178
Is helical tomotherapy-based intensity-modulated radiotherapy feasible and effective in bilateral synchronous breast cancer? A two-center experience. 61
27061530 2016
179
Innovative combination of therapeutic mammoplasty and expandable-implant breast augmentation for immediate partial breast reconstruction. 61
27132043 2016
180
Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes. 61
26770289 2016
181
Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore. 61
29263802 2016
182
Breast Sclerosing Adenosis and Accompanying Malignancies: A Clinicopathological and Imaging Study in a Chinese Population. 61
26656378 2015
183
Ewing Sarcoma in a Patient With Cowden Syndrome. 61
26553762 2015
184
Goldilocks mastectomy for obese Japanese females with breast ptosis. 61
23972507 2015
185
Breast-Conserving Surgery in Bilateral Breast Cancer. 61
26265365 2015
186
Comparative genomic analysis reveals bilateral breast cancers are genetically independent. 61
26378809 2015
187
Volumetric modulated arc therapy for synchronous bilateral whole breast irradiation - A case study. 61
26549999 2015
188
Synchronous Bilateral Breast Cancers. 61
26500995 2015
189
Bilateral breast cancer, synchronous and metachronous; differences and outcome. 61
26268697 2015
190
Multifocal Bilateral Breast Cancer and Breast Follicular Lymphoma: A Simple Coincidence? 61
26472982 2015
191
Bilateral breast cancer with a unilateral carcinoma within a fibroadenoma: A case report. 61
26622700 2015
192
Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast. 61
26472980 2015
193
A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes. 61
23242612 2015
194
Prostate cancer in a man with a BRCA2 mutation and a personal history of bilateral breast cancer. 61
25112434 2015
195
Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients. 61
26183948 2015
196
Bilateral breast cancer following augmentation mammaplasty with polyacrylamide hydrogel injection: A case report. 61
26137129 2015
197
Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features. 61
25678442 2015
198
Radiation induced depigmentation disorder in two patients with breast cancer: Exploring a rare accompaniment. 61
25708302 2015
199
Sarcoma of the breast and chest wall after radiation treatment for bilateral breast carcinoma. 61
25788453 2015
200
The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. 61
25863477 2015
201
Metabolic flare phenomenon on 18 fluoride-fluorodeoxy glucose positron emission tomography-computed tomography scans in a patient with bilateral breast cancer treated with second-line chemotherapy and bevacizumab. 61
25829734 2015
202
Stewart-Treves Syndrome after Bilateral Mastectomy and Radiotherapy for Breast Carcinoma: Case Report. 61
28331699 2015
203
Use of tomotherapy in treatment of synchronous bilateral breast cancer: dosimetric comparison study. 61
25605345 2015
204
Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li-Fraumeni syndrome. 61
25226867 2015
205
Bilateral breast radiation delivered with static angle tomotherapy (TomoDirect): clinical feasibility and dosimetric results of a single patient. 61
25702655 2015
206
Intrafraction variability and deformation quantification in the breast. 61
25680602 2015
207
Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors. 61
26554380 2015
208
Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer. 61
25866690 2015
209
The CHEK2 1100delC allelic variant is not present in familial and sporadic breast cancer cases from Moroccan population. 61
25674498 2015
210
Bilateral synchronous carcinoma breast- a rare case presentation. 61
25932376 2015
211
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 61
26399842 2015
212
[Synchronous association of a bilateral breast cancer and a gastrointestinal stromal tumor: report of a rare case]. 61
26090003 2015
213
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden. 61
26082817 2015
214
Surgical management for early-stage bilateral breast cancer patients in China. 61
25874699 2015
215
Impact of bilateral breast cancer on prognosis: synchronous versus metachronous tumors. 61
25735321 2015
216
A case of synchronous multiple bilateral breast cancer after breast augmentation. 61
26722625 2015
217
Bilateral breast cancer among three Yoruba women in a Nigerian teaching hospital. 61
30363615 2015
218
Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up. 61
26163616 2015
219
[Synchronous bilateral breast cancer in Morocco: epidemiological and clinical characteristics]. 61
26090066 2015
220
Predictors for contralateral prophylactic mastectomy in breast cancer patients. 61
26097557 2015
221
Pancreatic intraepithelial neoplasia arising from an ectopic pancreas in the small bowel. 61
25475871 2014
222
Clinical manifestations and radiological features may contribute to the early diagnosis of radiation-induced sarcoma after breast cancer. 61
25266762 2014
223
[Using skin graft for local control in stage IV breast cancer to improve quality of life]. 61
25731370 2014
224
A DNA repair variant in POLQ (c.-1060A > G) is associated to hereditary breast cancer patients: a case-control study. 61
25409685 2014
225
[A case of malignant phyllodes tumor after surgery for breast cancer]. 61
25731378 2014
226
Primary squamous cell carcinoma of the breast after cured bilateral breast cancer. 61
25398815 2014
227
A clinico-pathological study on cancer in sclerosing adenosis. 61
23408123 2014
228
Are bilateral breast cancers and breast cancers coexisting with ovarian cancer different from solitary tumors? A pair-matched immunohistochemical analysis aimed at intrinsic tumor phenotype. 61
25296577 2014
229
Multiple primary cancers as a guide to heritability. 61
24945890 2014
230
The actual scenario of neoadjuvant chemotherapy of breast cancer in developing country: a report of 80 cases of breast cancer from a tertiary cancer center in India. 61
24894013 2014
231
Role of sonography in the differentiation of benign, high-risk, and malignant papillary lesions of the breast. 61
25154934 2014
232
Novel BRCA1 deleterious mutation (c.1918C>T) in familial breast and ovarian cancer syndrome who share a common ancestry. 61
24633894 2014
233
Morphoimmunohistochemical characteristics of synchronous bilateral breast cancer. 61
25257431 2014
234
Bilateral synchronous breast cancer. 61
25420392 2014
235
Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies. 61
25007962 2014
236
Primary synchronous bilateral breast cancer. 61
25494117 2014
237
Periductal stromal tumor of the breast with synchronous bilateral breast cancer. 61
24982380 2014
238
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. 61
24951267 2014
239
The prevalence of BRCA1/2 mutations of triple-negative breast cancer patients in Xinjiang multiple ethnic region of China. 61
24961674 2014
240
Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan. 61
24800917 2014
241
An effective 5-fluorouracil, levofolinate, and oxaliplatin therapy for recurrent breast cancer: a case report. 61
24969166 2014
242
[Metrorrhagia disclosing a synchronous bilateral breast cancer: report of a case]. 61
24411296 2014
243
Male breast cancer: presenting as synchronous, large, bilateral masses. 61
24959456 2014
244
Appearance of estrogen positive bilateral breast carcinoma with HER2 gene amplification in a patient with aplastic anemia. 61
25119012 2014
245
Clinicopathological study of non-palpable familial breast cancer detected by screening mammography and diagnosed as DCIS. 61
22875640 2014
246
Appropriate evaluation of and risk factors for radiation dermatitis in breast cancer patients receiving hypofractionated whole-breast irradiation after breast-conserving surgery. 61
22492066 2014
247
Missense mutations (p.H371Y, p.D438Y) in gene CHEK2 are associated with breast cancer risk in women of Balochistan origin. 61
24390236 2014
248
Breast cancer and pacemakers. 61
23858021 2014
249
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer. 61
24498881 2014
250
A rare recurrence of bilateral breast cancer in the esophagus coincidentally associated with primary gastric cancer: a case report. 61
24533645 2014
251
Clinically significant missense variants in human GALNT3, GALNT8, GALNT12, and GALNT13 genes: intriguing in silico findings. 61
24038392 2014
252
[Role of imaging procedures in the diagnosis of synchronous bilateral breast cancer]. 61
24309024 2014
253
A clinicopathological study of early-stage synchronous bilateral breast cancer: a retrospective evaluation and prospective validation of potential risk factors. 61
24736632 2014
254
Serum p53 antibody in breast cancer. 61
24934362 2014
255
[Bilateral breast cancer: risk factors, prognostic factors and patient monitoring]. 61
25796820 2014
256
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. 61
24744928 2014
257
Double heterozygosity in the BRCA1 and BRCA2 genes in Italian family. 61
23940062 2013
258
A rare coincidence: facioscapulohumeral muscular dystrophy and breast cancer. 61
24382443 2013
259
Histo-biological comparative analysis of bilateral breast cancer. 61
24062258 2013
260
A case of synchronous bilateral breast cancer with different pathological responses to neoadjuvant chemotherapy with different biological character. 61
23875131 2013
261
Receptor status of tumor as prognostic factor in patients with bilateral breast cancer. 61
24382440 2013
262
Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma. 61
24373500 2013
263
Chest wall sarcoma: 18F-FDG PET/CT in a patient with Li-Fraumeni syndrome. 61
24107814 2013
264
Evaluation of clinico: pathologic findings of breast carcinoma in a general hospital in Southern India. 61
24369200 2013
265
Prognostic effect of preoperative serum estradiol level in postmenopausal breast cancer. 61
24160328 2013
266
Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. 61
24042365 2013
267
Case report of small bowel obstruction caused by small intestinal metastasis of bilateral breast cancer. 61
24137245 2013
268
BRCA1 gene Molecular Alterations in Omani Breast Cancer Patients. 61
23996866 2013
269
Renal Medullary Carcinoma Masquerading as Bilateral Breast Carcinoma Category: Case Report. 61
29147351 2013
270
Breast implant foreign body reaction mimicking breast cancer recurrence on FDG PET/CT. 61
23640240 2013
271
[Synchronous bilateral breast cancer in a male]. 61
23769252 2013
272
Primary dermal melanoma in a patient with a history of multiple malignancies: a case report with molecular characterization. 61
23904845 2013
273
A young woman with bilateral breast cancer: identifying a genetic cause and implications for management. 61
23667202 2013
274
The prognosis of synchronous and metachronous bilateral breast cancer in Chinese patients. 61
23296702 2013
275
Impact of presurgical breast magnetic resonance imaging (MRI) on surgical planning - a retrospective analysis from a private radiology group. 61
23294216 2013
276
[Bilateral breast cancer and Peutz-Jeghers syndrome]. 61
23254145 2013
277
Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation. 61
23104382 2013
278
Case report: Breast cancer associated with contralateral tuberculosis of axillary lymph nodes. 61
23432978 2013
279
Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil. 61
23406386 2013
280
Cancer problem in Peutz-Jeghers syndrome. 61
23977663 2013
281
Synchronous bilateral solid papillary carcinomas of the breast. 61
23844308 2013
282
[Precursors of breast cancer]. 61
24325156 2013
283
[Bilateral breast cancer (epidemiological aspects)]. 61
23909045 2013
284
Synchronous bilateral breast cancer in a male. 61
24319497 2013
285
The molecular and clinicopathologic characteristics of bilateral breast cancer. 61
24005135 2013
286
Lymphedema. A significant health problem for women with breast cancer in Jordan. 61
23299161 2013
287
Patient and tumor characteristics associated with breast cancer recurrence after complete pathological response to neoadjuvant chemotherapy. 61
23149464 2013
288
Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer. 61
23255899 2013
289
Nipple- or skin-sparing mastectomy and immediate breast reconstruction by the "moving window" operation. 61
22038670 2013
290
Germline mutations in RAD51C in Jewish high cancer risk families. 61
23117857 2012
291
Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence. 61
23083502 2012
292
Papillary-serous adenocarcinoma of the uterine cervix during tamoxifen therapy after bilateral breast cancer. 61
23155282 2012
293
Less scarring or more symmetry? Reconstruction following metachronous bilateral breast cancer. 61
22560454 2012
294
[A long-surviving case of HER2-positive breast cancer with brain metastasis treated by multidisciplinary therapy]. 61
23267980 2012
295
Dosimetric advantages of generalised equivalent uniform dose-based optimisation on dose-volume objectives in intensity-modulated radiotherapy planning for bilateral breast cancer. 61
23091290 2012
296
Prone accelerated partial breast irradiation after breast-conserving surgery: five-year results of 100 patients. 61
22494589 2012
297
Clinical impact of (18)F-FDG PET/CT on initial staging and therapy planning for breast cancer. 61
23170128 2012
298
A case of synchronous metastasis of breast cancer to stomach and colon. 61
22993359 2012
299
Associations between BRCA Mutations in High-Risk Breast Cancer Patients and Familial Cancers Other than Breast or Ovary. 61
23091540 2012
300
Tumor seeding after diagnostic vitrectomy for choroidal metastasis in breast cancer. 61
22989547 2012
301
Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review. 61
23691479 2012
302
[Diagnosis of metachronous bilateral breast cancer]. 61
23350406 2012
303
Radiofrequency thermoablation in locally advanced breast cancer. 61
22386281 2012
304
Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients. 61
22438049 2012
305
Three cases of kindred with familial breast cancer in which carrier detection by BRCA gene testing was performed on family members. 61
19806429 2012
306
Circulating tumour cells in non-metastatic breast cancer: a prospective study. 61
22677156 2012
307
Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer. 61
22713658 2012
308
Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature. 61
22672556 2012
309
Synchronous bilateral male breast cancer: a case report. 61
22807945 2012
310
Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study. 61
22382806 2012
311
Is short-interval mammography necessary after breast conservation surgery and radiation treatment in breast cancer patients? 61
22245193 2012
312
Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients. 61
21945313 2012
313
Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer. 61
22237454 2012
314
SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation. 61
22469291 2012
315
Synchronous bilateral breast cancer in a patient with kindler syndrome. 61
22054710 2012
316
[The clinical study of familial breast cancer - now and the problems]. 61
22504672 2012
317
Frequency of the CHEK2 1100delC mutation among women with early-onset and bilateral breast cancer. 61
22520019 2012
318
Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience. 61
21193967 2012
319
Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer. 61
22816241 2012
320
Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique. 61
22019349 2012
321
Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing. 61
21553119 2012
322
Clinicopathological features in bilateral breast cancer. 61
23167382 2012
323
Synchronous bilateral breast carcinoma and axillary non-hodgkin lymphoma: a case report and review of the literature. 61
23050177 2012
324
Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients. 61
21847643 2012
325
Survival from synchronous bilateral breast cancer: the experience of surgeons participating in the breast audit of the Society of Breast Surgeons of Australia and New Zealand. 61
22799341 2012
326
Synchronous bilateral medullary carcinoma of breast: is it metastasis or second primary? 61
22531532 2012
327
Estrogen receptor, progesterone receptor, and Her 2 Neu positivity and its association with tumour characteristics and menopausal status in a breast cancer cohort from northern Pakistan. 61
23304239 2012
328
A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes. 61
22105824 2011
329
Pregnancy a short time after multimodal therapy for bilateral breast cancer: a case report and review of literature. 61
20858636 2011
330
Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome. 61
22185575 2011
331
[A case of scalp metastases from breast cancer successfully treated with letrozole]. 61
22202323 2011
332
Bilateral primary breast neuroendocrine carcinoma in a young woman: report of a case. 61
21969166 2011
333
Perceptions of contralateral breast cancer: an overestimation of risk. 61
21947590 2011
334
A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer. 61
21989022 2011
335
Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study. 61
21553118 2011
336
Preoperative Systemic Treatment in BRCA-Positive Breast Cancer Patients: Case Report and Review of the Literature. 61
22619651 2011
337
The Korean Hereditary Breast Cancer (KOHBRA) study: protocols and interim report. 61
21497495 2011
338
Detection of bilateral breast cancer at biennial screening mammography in the Netherlands: a population-based study. 61
21474705 2011
339
Prognosis of early-stage synchronous bilateral invasive breast cancer. 61
21628090 2011
340
Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. 61
22109790 2011
341
Helical tomotherapy in patients with breast cancer and complex treatment volumes. 61
21493188 2011
342
Electron arc therapy for bilateral chest wall irradiation: treatment planning and dosimetric study. 61
21185700 2011
343
Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. 61
21093260 2011
344
PALB2 mutations in German and Russian patients with bilateral breast cancer. 61
21165770 2011
345
Current status of diagnosis and treatment of primary breast cancer in beijing, 2008. 61
23467615 2011
346
Solitary small bowel metastasis from breast cancer. 61
21847398 2011
347
[A case of possible retroperitoneal metastasis of breast cancer successfully treated with oral S-1 and cyclophosphamide therapy after TC therapy]. 61
21403449 2011
348
Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution. 61
20972632 2011
349
Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. 61
20665107 2011
350
Bilateral DCIS following gynecomastia surgery. Role of nipple sparing mastectomy. A case report and review of literature. 61
22096697 2011
351
Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer: evaluation with MRI and vacuum-assisted core needle biopsy and safety management. 61
20204556 2011
352
[Li-Fraumeni syndrome: clinico-molecular diagnostics and medico-genetic counseling]. 61
22379889 2011
353
Bilateral breast cancer: a male patient. 61
21954546 2011
354
Bilateral breast carcinoma- a rare case report. 61
21505580 2011
355
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas. 61
20838878 2011
356
The risk factors and prognosis of bilateral primary breast cancer: a comparative study with unilateral breast cancer. 61
21473293 2011
357
Concurrent breast stroma sarcoma and breast carcinoma: a case report. 61
21182764 2010
358
Non-founder BRCA1 mutations in Russian breast cancer patients. 61
20727672 2010
359
[A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock]. 61
21160270 2010
360
Bilateral breast carcinoma: clinical characteristics and its impact on survival. 61
21070440 2010
361
Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America. 61
20875877 2010
362
Early results of an endoscopic nipple-sparing mastectomy for breast cancer. 61
22695768 2010
363
Weekly paclitaxel improved pathologic response of primary chemotherapy compared with standard 3 weeks schedule in primary breast cancer. 61
20582466 2010
364
BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries. 61
20472656 2010
365
Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer. 61
19875753 2010
366
Synchronous bilateral breast carcinoma with two different morphology subtypes: a case report. 61
20698158 2010
367
Bilateral breast cancer in a survivor of acute lymphoblastic leukemia: a case report. 61
19472087 2010
368
Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer. 61
20211870 2010
369
Evaluating cancer epidemiologic risk factors using multiple primary malignancies. 61
20299982 2010
370
Erdheim-chester disease presenting as bilateral clinically malignant breast masses. 61
20216377 2010
371
Severe venous and lymphatic obstruction after single-chamber pacemaker implantation in a patient with chest radiation therapy. 61
20025702 2010
372
Synchronous bilateral breast cancer in a patient with Klinefelter's syndrome. 61
20463819 2010
373
Ovarian metastases from breast cancer: report of 29 cases. 61
20041486 2010
374
Four different malignancies in one patient: a case report. 61
20205852 2010
375
Clinical experience with image-guided radiotherapy in an accelerated partial breast intensity-modulated radiotherapy protocol. 61
19467799 2010
376
Case report. PET/CT appearance of desmoid tumour of the chest wall. 61
20139256 2010
377
[Microsatellite instability of bilateral breast carcinomas is not linked to down-regulated expression of DNA mismatch repair genes]. 61
20552889 2010
378
Synchronous bilateral breast cancer in an aged male patient. 61
20502060 2010
379
Bilateral breast carcinoma in patients with Klinefeleter syndrome: report of case. 61
21246928 2010
380
Synchronous bilateral breast carcinoma in a patient with cowden syndrome: a case report with morphologic, immunohistochemical and genetic analysis. 61
19968660 2010
381
Early results of an endoscopic nipple-sparing mastectomy for breast cancer. 61
19662457 2009
382
[A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel]. 61
20037459 2009
383
Cutaneous angiosarcoma after breast conserving treatment for bilateral breast cancers in a BRCA-1 gene mutation carrier--a case report and review of the literature. 54
19736894 2009
384
Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy. 61
19630947 2009
385
Recovery of ventricular function with a left ventricular axial pump in a patient with end-stage toxic cardiomyopathy not a candidate for heart transplantation: first experience in Spain. 61
19715885 2009
386
No breast cancer association for transforming growth factor-beta pathway colorectal cancer single nucleotide polymorphisms. 61
19505925 2009
387
Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer. 61
19593618 2009
388
Scintimammography with high resolution dedicated breast camera and mammography in multifocal, multicentric and bilateral breast cancer detection: a comparative study. 61
18432183 2009
389
Prognosis of synchronous bilateral breast cancer. 61
19283743 2009
390
Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci. 61
19147119 2009
391
Cumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese women. 61
19190627 2009
392
Hypercalcaemia in breast cancer patients: not always bony metastases. 61
21686968 2009
393
Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls. 61
19124502 2009
394
Synchronous bilateral mucinous carcinoma of the breast: case report. 61
19135933 2009
395
[Three cases of second primary lung cancer after radiotherapy for breast cancer]. 61
19198231 2009
396
Genetic counseling can influence the course of a suspected familial cancer syndrome patient: from a case of Li-Fraumeni like syndrome with a germline mutation in the TP53 gene. 61
19127115 2008
397
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. 61
18556141 2008
398
Adjacent thoracic lymph node metastases originating from two separate primary cancers: case report. 61
18831741 2008
399
Diagnostic and prognostic utility of molecular markers in synchronous bilateral breast carcinoma. 61
18469799 2008
400
Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. 61
19016756 2008
401
Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. 61
18722264 2008
402
Breast cancer onset in twins and women with bilateral disease. 61
18591548 2008
403
A safe and effective method to implant a totally implantable access port in patients with synchronous bilateral mastectomies: modified femoral vein approach. 61
18704915 2008
404
Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families. 61
18783588 2008
405
A family history of breast cancer will not predict female early onset breast cancer in a population-based setting. 61
18651949 2008
406
A novel mutation of the PTEN gene in a Japanese patient with Cowden syndrome and bilateral breast cancer. 61
18558293 2008
407
Bilateral Paget disease of the male nipple: first report. 61
18171616 2008
408
Primary lymphoma of the breast involving both axillae with bilateral breast carcinoma. 61
18492251 2008
409
Assessment of surgical treatment in elderly patients with breast cancer. 61
18705397 2008
410
Bilateral breast cancer in a male patient with hepatocellular carcinoma. A case report. 61
18727274 2008
411
Synchronous bilateral breast cancer with different biological profile and estrogen-progesterone receptor status. 61
18298610 2008
412
Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group. 61
18250348 2008
413
Clinicopathological characteristics of synchronous bilateral breast carcinomas. Report of 30 patients. 61
18444533 2008
414
Case 32-2007: bilateral breast cancer. 61
18305276 2008
415
Significance of irradiation in breast-conserving treatment: comparison of local recurrence rates in irradiated and nonirradiated groups. 61
18307014 2008
416
Mutation analysis of the MDM4 gene in German breast cancer patients. 61
18279506 2008
417
Role of sonography in the detection of contralateral metachronous breast cancer in an Asian population. 61
18212235 2008
418
Correlation of whole-breast vascularity with ipsilateral breast cancers using contrast-enhanced MDCT. 61
18212238 2008
419
Detection of bilateral, multifocal breast cancer and assessment of tumour response to neoadjuvant chemotherapy by Tc-99m sestamibi imaging - a case report. 61
19585458 2008
420
Bilateral breast MR imaging: is it superior to conventional methods for the detection of contralateral breast cancer? 61
18317885 2008
421
Simultaneous diagnosis and treatment of bilateral breast carcinoma and endometrial adenocarcinoma. Implications for screening. 61
19051825 2008
422
[Synchronous bilateral breast cancer: risk factors, diagnosis, histology and treatment]. 61
18178120 2008
423
Oncoplastic surgery after mammary reduction and mastopexy for bilateral breast cancer lesions: report of a case. 61
18368323 2008
424
Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival. 61
18269777 2007
425
Survival after bilateral breast cancer: results from a population-based study. 61
17186359 2007
426
Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision. 61
17629481 2007
427
Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation. 61
17572079 2007
428
Incidence and prognosis of synchronous and metachronous bilateral breast cancer. 61
17878475 2007
429
Searching for susceptibility alleles: emphasis on bilateral breast cancer. 61
17444500 2007
430
Bilateral breast cancer: differential diagnosis using histological and biological parameters. 61
17673471 2007
431
[Simultaneous bilateral breast carcinoma--case study and review of primitive bilateral breast cancer]. 61
17966947 2007
432
Bilateral male breast cancer with male potential hypogonadism. 61
17543123 2007
433
Incidental discovery of bilateral breast cancer in a 24-year-old man presenting with gynecomastia. 61
17522493 2007
434
Use of ultrasonography as an alternative modality for first-line examination in detecting breast cancer in selected patients. 61
17592675 2007
435
Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in Southern India. 61
17519044 2007
436
Synchronous bilateral breast cancer in men: a case report and review of the literature. 61
17557578 2007
437
Genetic changes in bilateral breast cancer by comparative genomic hybridisation. 61
17380298 2007
438
Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. 61
17206485 2007
439
Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia. 61
17333477 2007
440
Mucinous cystadenoma arising in an isolated ileal duplication cyst. 61
19089665 2007
441
US findings of bilateral primary breast cancer: retrospective study. 61
17064869 2007
442
Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer. 61
17244989 2007
443
Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. 61
16978974 2006
444
[Case report of advanced breast cancer responding to capecitabine and trastuzumab combination therapy]. 61
17033236 2006
445
Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent. 61
16965326 2006
446
[Onycholysis with hyponychium exudate secondary to chemotherapy with paclitaxel and capecitabine]. 61
17067535 2006
447
[Bilateral breast cancer (BBC). Considerations on a series of 20 cases]. 61
17438890 2006
448
Human leukocyte antigen as a predictive factor of developing bilateral breast cancer in Japanese women. 61
16959002 2006
449
Family history of breast cancer as a risk factor for ovarian cancer in a prospective study. 61
16881078 2006
450
Clinical significance of CK5/6 and PTEN protein expression in patients with bilateral breast carcinoma. 61
16918971 2006
451
HER2 status in bilateral breast cancer. 61
17269588 2006
452
Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan. 61
16544057 2006
453
Diabetes insipidus and adrenal insufficiency in a patient with metastatic breast cancer. 61
16990696 2006
454
ATM variants and cancer risk in breast cancer patients from Southern Finland. 61
16914028 2006
455
On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer. 61
16496408 2006
456
Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. 61
16770759 2006
457
Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family. 61
16772121 2006
458
[Secondary breast bilateral reconstruction with myocutaneous pedicled latissimus dorsi flap after primary bilateral skin sparing mastectomy reconstruction with consecutive severe capsular contraction]. 61
17087135 2006
459
High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. 61
16737811 2006
460
[Expression and clinical significance of KNSL4 in breast cancer]. 61
16764773 2006
461
Synchronous breast cancer in spouses. 61
16869244 2006
462
Evolving concepts in the management of lobular neoplasia. 61
16687097 2006
463
Histopathological types of breast cancer in Nigerian women: a 12-year review (1993-2004). 61
16999196 2006
464
High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma. 61
16475207 2006
465
A case of bilateral breast cancer with Peutz-Jeghers syndrome. 61
16246518 2006
466
[Bilateral breast bacterial cellulite secondary to Streptococcus agalactiae septicemia]. 61
16508605 2006
467
A case of metachronous bilateral breast cancer with bilateral radiation pneumonitis after breast-conserving therapy. 61
16929127 2006
468
Synchronous bilateral breast carcinoma in a 50-year-old man with 45,X/46,XY mosaic karyotype: report of a case. 61
16378198 2006
469
Primary gynecological neoplasms and clinical outcomes in patients diagnosed with breast carcinoma. 61
16515578 2006
470
Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County. 61
16858627 2006
471
Low frequency of the CHEK2*1100delC mutation among breast cancer probands from three regions of Poland. 61
16830057 2006
472
[Breast cancer and pregnancy: a study of 3 cases]. 61
16450949 2005
473
Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population. 61
16136597 2005
474
Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study. 61
16257342 2005
475
Simultaneous bilateral breast cancer in a male: a case report and review of the literature. 61
16315841 2005
476
Synchronous bilateral Paget's disease of the nipple associated with bilateral breast carcinoma. 61
16174159 2005
477
Complementary role of adjunctive breast magnetic resonance imaging and scintimammography in patients of all ages undergoing breast cancer surgery. 61
16026435 2005
478
Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel. 61
16030426 2005
479
Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile. 61
15944928 2005
480
Breast-conserving therapy in patients with bilateral breast cancer: do today's treatment choices burn bridges for tomorrow? 61
15890578 2005
481
Genetic implications of bilateral breast cancer: a population based cohort study. 61
15925815 2005
482
Bilateral breast cancer. Incidence, diagnosis and histological patterns. 61
15900371 2005
483
NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. 61
15578693 2005
484
[Three cases of advanced breast cancer successfully treated with a weekly dose of paclitaxel]. 61
15853223 2005
485
Synchronous bilateral breast cancer in an elderly man. 61
15730469 2005
486
Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ. 61
15827818 2005
487
Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients. 61
15472904 2005
488
Strong evidence that the common variant S384F in BRCA2 has no pathogenic relevance in hereditary breast cancer. 61
16168123 2005
489
[The bilateral breast cancer in patient treated for Ewing sarcoma in childhood--the case report]. 61
16786799 2005
490
High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. 61
16168118 2005
491
Bilateral breast-conserving therapy for bilateral breast cancer: results and consideration of radiation technique. 61
15858445 2005
492
Genetics and the young woman with breast cancer. 61
16823163 2005
493
The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer. 61
16110289 2005
494
Morphologically similar epithelial and stromal cells in primary bilateral breast tumors display different genetic profiles: implications for treatment. 61
15536329 2004
495
[Breast cancer and quality of life--improvement by contralateral breast reconstruction and symmetrical mammaplasty?]. 61
15633083 2004
496
Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. 61
15507181 2004
497
A case of bilateral breast cancer and Graves' disease. 61
15656338 2004
498
Prenatal diagnosis in Li-Fraumeni syndrome. 61
15342977 2004
499
Bilateral autogenous breast reconstruction using perforator free flaps: a single center's experience. 61
15220573 2004
500
Management of bilateral breast carcinoma: long-term results. 61
15521255 2004
501
Metastasis of breast carcinoma to intracranial meningioma. 61
15550902 2004
502
Phenotypic similarities in bilateral breast cancer. 61
15111764 2004
503
Contrast-enhanced MR imaging of breast lesions and effect on treatment. 61
15135477 2004
504
Bilateral carcinomas of the breast with local recurrence: analysis of genetic relationship of the tumors. 61
15017434 2004
505
A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls. 61
15042666 2004
506
Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients. 61
15082902 2004
507
A case of fat necrosis after breast quadrantectomy in which preoperative diagnosis was enabled by MRI with fat suppression technique. 61
15010123 2004
508
[Bilateral breast cancer. Incidence and risk factors]. 61
15123135 2004
509
Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama. 61
15280184 2004
510
Molecular study of clonality in multifocal and bilateral breast tumors. 61
15648612 2004
511
The pattern of gene copy number changes in bilateral breast cancer surveyed by cDNA microarray-based comparative genomic hybridization. 61
14654965 2004
512
Risk estimation for healthy women from breast cancer families: new insights and new strategies. 61
14744738 2004
513
Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers. 61
14997059 2004
514
Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. 61
15084244 2004
515
The DNMT3B C-->T promoter polymorphism and risk of breast cancer in a British population: a case-control study. 61
15217506 2004
516
Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients. 61
14574485 2003
517
Malignant mixed mullerian tumor of the ovary and bilateral breast cancer: an argument for BRCA3, or a coincidental cluster of unconnected cancers? 61
14599878 2003
518
Molecular cytogenetic investigations of synchronous bilateral breast cancer. 61
12944548 2003
519
Therapeutic controversies in bilateral breast cancer. 61
12924462 2003
520
[Anesthesia for a patient with Kartagener's syndrome undergoing ambulatory bilateral breast cancer surgery]. 61
13677279 2003
521
[Bilateral breast cancer]. 61
12903583 2003
522
[Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer]. 61
12883794 2003
523
Heart transplantation in chemotherapeutic dilated cardiomyopathy. 61
12826209 2003
524
Bilateral breast cancer associated with diffuse scleroderma. 61
14659331 2003
525
Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation. 61
12798754 2003
526
Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer. 61
12752622 2003
527
Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features. 61
12715337 2003
528
Synchronous, bilateral breast cancer: prognostic value and incidence. 61
14659335 2003
529
Molecular pathogenesis of bilateral breast cancer. 61
12609703 2003
530
Synchronous bilateral breast cancer with Paget's disease and invasive ductal carcinoma: report of a case. 61
12924421 2003
531
Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire. 61
12558666 2003
532
Primary squamous cell carcinoma of the breast. 61
14584651 2003
533
Factors influencing mortality among young women with second primary breast carcinoma. 61
12412157 2002
534
Distinct prevalence of the CYP19 Delta3(TTTA)(7) allele in premenopausal versus postmenopausal breast cancer patients, but not in control individuals. 61
12204674 2002
535
Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas. 61
12124805 2002
536
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. 61
12094328 2002
537
The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours. 61
12099647 2002
538
Breast-conservation treatment for bilateral breast cancer in five Japanese women. 61
11956611 2002
539
Lumpectomy and breast radiotherapy in breast cancer patients with a family history of breast cancer, ovarian cancer, or both. 61
12047472 2002
540
Bilateral synchronous breast cancer and HER-2/neu overexpression. 61
12058961 2002
541
Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population. 61
12362976 2002
542
Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases. 61
12459717 2002
543
Limitations of the Gail model in the specialized breast cancer risk assessment clinic. 61
11856157 2002
544
Bilateral breast cancer. 61
12044060 2002
545
Histological grade, p53, HER2 and hormone receptor status of synchronous bilateral breast carcinoma. 61
12016392 2002
546
Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. 61
12473175 2002
547
Tubular breast cancer experience at Washington University: a review of the literature. 61
11899414 2001
548
Prognostic significance of synchronous and metachronous bilateral breast cancer. 61
11571945 2001
549
Multifocal squamous cell carcinoma of the oesophagus following radiotherapy for bilateral breast carcinoma. 61
11533082 2001
550
[A case of breast cancer with bone marrow and liver metastases responding completely to low-dose weekly paclitaxel combined with toremifene]. 61
11579642 2001
551
Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. 61
11504767 2001
552
[Bilateral breast carcinoma and local recurrence: prevalence of BRCA-1 and BRCA-2 gene mutations in an unselected patient sample]. 61
11505617 2001
553
Leiomyomatosis peritonealis disseminata and ovarian Brenner tumor associated with tamoxifen use. 61
11520371 2001
554
Understanding mathematical models for breast cancer risk assessment and counseling. 61
11678799 2001
555
Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male. 61
11434671 2001
556
[Sentinel lymph node biopsy in breast cancer: a validation study and preliminary results]. 61
11420841 2001
557
Caucasian family with two independent mutations: 2594delC in BRCA1 and 5392delAG in BRCA2 gene. 61
11391658 2001
558
[Arm morbidity after axillary dissection for breast cancer]. 61
11434124 2001
559
Radioimmunoguided breast surgery using radiolabeled antibody NR-LU-10 FAB: a pilot study. 61
11504368 2001
560
Contralateral breast cancer: molecular differentiation between metastasis and second primary cancer. 61
11518461 2001
561
Differences in estrogen receptor status, HER2, and p53 comparing metachronous bilateral breast carcinoma. 61
11344480 2001
562
A case-control study of unilateral and bilateral breast carcinoma patients. 61
11346865 2001
563
Bilateral breast cancer--under age 20 years. 61
11287255 2001
564
What about the other breast? A review of a series of bilateral breast carcinomas. 61
14965575 2001
565
[Particular clinical aspect of breast cancer]. 61
12731152 2001
566
Radiation-induced chromatid breaks as a predictor of breast cancer risk. 61
11173151 2001
567
The diagnostic accuracy of mammography in the evaluation of male breast disease. 61
11425067 2001
568
Protein accumulation and gene mutation of p53 in bilateral breast cancer. South-East Sweden Breast Cancer Group. 61
11321662 2001
569
3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: clinical results and future perspectives with reference to FDG-PET. 61
11791129 2001
570
Familial breast cancer: an investigation into the outcome of treatment for early stage disease. 61
14573999 2001
571
Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. 61
11094304 2000
572
Loss of heterozygosity in bilateral breast cancer. 61
11200774 2000
573
Local-regional control in breast cancer patients with a possible genetic predisposition. 61
11072150 2000
574
Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. 61
11015105 2000
575
[Germ-line mutations of the BRCA1 gene in northeastern France]. 61
11084537 2000
576
Familial cancer risks to offspring from mothers with 2 primary breast cancers: leads to cancer syndromes. 61
10962444 2000
577
Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients. 61
10952774 2000
578
CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women. 61
10840158 2000
579
The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy. 61
11038147 2000
580
[Characteristics of familial breast cancer]. 61
10921313 2000
581
Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. 61
10870056 2000
582
Incidence and Detection of Contralateral Breast Cancer. 61
11348361 2000
583
Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery. 61
10861612 2000
584
Multiple radiculopathy of the lower limbs in a cancer patient with meningeal carcinomatosis. 61
10938191 2000
585
Bilateral male breast cancer and prostate cancer: a case report. 61
10830988 2000
586
[++Scintimammography: a new imaging technique for diagnosis and follow-up of breast cancer]. 61
10827352 2000
587
Prophylactic mastectomy: pathologic findings in high-risk patients. 61
10705389 2000
588
Management of breast cancer after Hodgkin's disease. 61
10673517 2000
589
ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. 61
10677309 2000
590
Detection of bilateral multifocal breast cancer using Tc-99m sestamibi imaging. The role of delayed imaging. 61
10439180 1999
591
Linkage analysis and loss of heterozygosity for chromosome arm 1p in familial breast cancer. 61
10398429 1999
592
BRCA1 mutations in African Americans. 61
10480351 1999
593
Bilateral breast carcinomas: do they have similar mammographic features? 61
10437693 1999
594
Familial risks in second primary breast cancer based on a family cancer database. 61
10448299 1999
595
[A case of pleural and mediastinal lymph node metastases from breast cancer effectively treated with fadrozole hydrochloride in combination with cyclophosphamide]. 61
10065105 1999
596
Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study. 61
10027348 1999
597
Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer. 61
10030422 1999
598
Efficacy of Breast Conservation Therapy in Early Stage Bilateral Breast Cancer. 61
11348254 1999
599
Quadruple cancer including bilateral breasts, Vater's papilla, and urinary bladder: report of a case. 61
10192743 1999
600
Evolving perspectives in contralateral breast cancer. 61
10070301 1998
601
[Vaginal metastases of breast cancer]. 61
9921442 1998
602
Bilateral Synchronous Spindle Cell, Apocrine and Scirrhous Carcinoma Breast Cancer in a Case of Malignant Lymphoma. 61
11091684 1998
603
Efficacious diagnosis of primary and metastatic human carcinomas with a combination of p53 mutation analysis and clonality analysis of androgen receptor gene. 61
9735408 1998
604
Microsatellite instability in breast cancers with special reference to patients' age and bilaterality. 61
9810779 1998
605
[The incidence of bilateral multiple primary breast cancer among the female inhabitants of Crimea]. 61
9844902 1998
606
Association of breast cancer with meningioma. 61
9725004 1998
607
BRCA1 mutations in southern England. 61
9649133 1998
608
Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour? 61
9797693 1998
609
BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. 61
9544766 1998
610
[Bilateral breast carcinoma--a retrospective analysis of 27 patients with a case report]. 61
9594636 1998
611
[Orbital and stomach metastasis from invasive lobular breast carcinoma]. 61
9513361 1998
612
[Bilateral breast cancer with neuroendocrine differentiation and a long course]. 61
9807215 1998
613
p53 mutations in bilateral breast carcinoma. Correlation with Ki-67 expression and the mean nuclear volume. 61
9464497 1998
614
Bilateral synchronous spindle cell, apocrine and scirrhous carcinoma breast cancer in a case or malignant lymphoma. 61
18843558 1998
615
Mammographic and ultrasonographic findings in bilateral breast cancer: a comparative study. 61
9569339 1998
616
Medico-genetic and cytogenetic study of a family with high predisposition to malignant disease in gastro-intestinal tract. 61
9505210 1997
617
Bilateral breast carcinoma versus unilateral disease. Review of 498 patients. 61
9391536 1997
618
Clinicopathological Features of Hereditary Breast Cancer. 61
11091606 1997
619
Early-stage bilateral breast cancer treated with breast-conserving surgery and definitive irradiation: the University of Pennsylvania experience. 61
9276360 1997
620
Breast-conserving therapy for stage I-II synchronous bilateral breast carcinoma. 61
9083159 1997
621
Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. 61
9142379 1997
622
Diet and premenopausal bilateral breast cancer: a case-control study. 61
9065608 1997
623
[Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases]. 61
9435820 1997
624
Pituitary adenoma and bilateral male breast cancer: an unusual association. 61
9040805 1997
625
Genetics of breast cancer. 61
9005288 1997
626
Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. 61
10464625 1997
627
Hereditary breast cancer in Northern Ireland. 61
8979776 1996
628
[Solitary fibrous tumor of the pleura. Clinical case]. 61
8992400 1996
629